Jusqu'où aller dans la désescalade thérapeutique en radiothérapie du cancer du sein infiltrant ?
- PMID: 27494982
- DOI: 10.1016/S0007-4551(16)30153-9
Jusqu'où aller dans la désescalade thérapeutique en radiothérapie du cancer du sein infiltrant ?
Abstract
WHERE CAN WE GO?: Adjuvant radiotherapy (RT) has an important role in the management of infiltrating breast cancer, not only to improve local control but also overall survival. So, all attempt of de-escalation must be performed in the context of large prospective studies. However, RT could induce some complications and last 5 to 7 weeks. Three ways of RT de-escalation have been studied.
Keywords: Breast cancer; Cancer du sein; Intra-operative; Irradiation partielle; Irradiation per-opératoire; Partial breast irradiation; Radiotherapy; Radiothérapie; irradiation.
© 2016 Société Française du Cancer. Publié par Elsevier Masson SAS.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
